US Stock MarketDetailed Quotes

LEXX Lexaria Bioscience

Watchlist

3.3800
+0.2900+9.39%

Close Jul 26 16:00 ET

3.3800
0.00000.00%

Post 20:01 ET

53.44MMarket Cap-7681P/E (TTM)

Lexaria Bioscience Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)May 31, 2024

(Q2)Feb 29, 2024

(Q1)Nov 30, 2023

(FY)Aug 31, 2023

(Q4)Aug 31, 2023

(Q3)May 31, 2023

(Q2)Feb 28, 2023

(Q1)Nov 30, 2022

(FY)Aug 31, 2022

(Q4)Aug 31, 2022

Total revenue

8.10%84K

624.09%145K

54.78%151.28K

-11.43%226.21K

-72.34%30.74K

-22.07%77.71K

-34.67%20.03K

604.14%97.74K

-64.66%255.4K

258.31%111.15K

Operating revenue

8.10%84K

624.09%145K

62.51%150.38K

13.67%190.97K

4.04%41.87K

-22.07%77.71K

-34.67%20.03K

1,221.93%92.54K

-76.61%168K

29.30%40.24K

Cost of revenue

-69.47%4.82K

-56.15%31.5K

-31.60%12.75K

-53.69%2.96K

183.57%15.8K

-59.03%71.84K

103.11%41.25K

Gross profit

29.31%84K

749.59%145K

78.74%146.46K

6.08%194.71K

-56.02%30.74K

-19.88%64.96K

-29.66%17.07K

886.04%81.94K

-66.47%183.56K

552.55%69.9K

Operating expense

-25.91%1.83M

-39.36%813.01K

-27.67%1.29M

-1.09%6.73M

39.88%1.14M

-1.34%2.47M

-8.98%1.34M

-11.65%1.78M

9.12%6.8M

-37.68%818.45K

Selling and administrative expenses

51.95%1.25M

-11.99%567.23K

-24.98%711.11K

-38.26%3.06M

39.41%644.45K

-52.77%825.18K

-46.17%644.51K

-38.97%947.87K

-0.23%4.96M

-47.08%462.26K

-General and administrative expense

51.95%1.25M

-11.99%567.23K

-24.98%711.11K

-38.26%3.06M

39.41%644.45K

-52.77%825.18K

-46.17%644.51K

-38.97%947.87K

-0.23%4.96M

-47.08%462.26K

Research and development costs

-65.07%573.09K

-64.70%245.78K

-30.74%574.49K

98.99%3.67M

40.49%500.41K

118.14%1.64M

152.53%696.18K

80.83%829.49K

45.91%1.84M

-19.01%356.19K

Operating profit

27.40%-1.74M

49.53%-668.01K

32.81%-1.14M

1.28%-6.53M

-48.84%-1.11M

0.72%-2.4M

8.63%-1.32M

15.38%-1.7M

-16.39%-6.62M

42.54%-748.55K

Net non-operating interest income expense

-100.01%-1

95.64%7.32K

43.19K

9.02K

15.44K

14.99K

3.74K

Non-operating interest income

--0

----

95.64%7.32K

--43.19K

--9.02K

--15.44K

--14.99K

--3.74K

--0

----

Non-operating interest expense

----

--1

----

Other net income (expense)

-2,330.23%-41.39K

862.51%15.27K

31.45%-53.22K

71.01%-221.69K

-143.92K

1.86K

-2K

-77.63K

-150.21%-764.61K

Gain on sale of security

-2,330.23%-41.39K

862.51%15.27K

31.45%-53.22K

71.01%-221.69K

---143.92K

--1.86K

---2K

---77.63K

---764.61K

----

Income before tax

25.14%-1.78M

50.20%-652.73K

33.02%-1.19M

9.09%-6.71M

17.46%-1.25M

1.44%-2.38M

9.53%-1.31M

11.69%-1.77M

-77.31%-7.38M

-16.16%-1.51M

Income tax

Net income

25.14%-1.78M

50.20%-652.73K

33.02%-1.19M

9.09%-6.71M

17.46%-1.25M

1.44%-2.38M

9.53%-1.31M

11.69%-1.77M

-76.38%-7.38M

-16.16%-1.51M

Net income continuous Operations

25.14%-1.78M

50.20%-652.73K

33.02%-1.19M

9.09%-6.71M

17.46%-1.25M

1.44%-2.38M

9.53%-1.31M

11.69%-1.77M

-77.31%-7.38M

-16.16%-1.51M

Minority interest income

78.29%-2.62K

74.46%-3.19K

57.23%-5.72K

58.34%-47.63K

78.78%-9.7K

65.94%-12.06K

45.38%-12.51K

-29.41%-13.36K

28.16%-114.33K

63.32%-45.7K

Net income attributable to the parent company

24.87%-1.78M

49.96%-649.54K

32.84%-1.18M

8.31%-6.66M

15.55%-1.24M

0.48%-2.37M

8.95%-1.3M

11.90%-1.76M

-80.51%-7.27M

-24.56%-1.47M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

24.87%-1.78M

49.96%-649.54K

32.84%-1.18M

8.31%-6.66M

15.55%-1.24M

0.48%-2.37M

8.95%-1.3M

11.90%-1.76M

-80.51%-7.27M

-24.56%-1.47M

Basic earnings per share

64.86%-0.13

72.73%-0.06

56.67%-0.13

18.55%-1.01

50.00%-0.12

9.76%-0.37

12.00%-0.22

14.29%-0.3

-30.53%-1.24

0.00%-0.24

Diluted earnings per share

64.86%-0.13

72.73%-0.06

56.67%-0.13

18.55%-1.01

50.00%-0.12

9.76%-0.37

12.00%-0.22

14.29%-0.3

-30.53%-1.24

0.00%-0.24

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q3)May 31, 2024	(Q2)Feb 29, 2024	(Q1)Nov 30, 2023	(FY)Aug 31, 2023	(Q4)Aug 31, 2023	(Q3)May 31, 2023	(Q2)Feb 28, 2023	(Q1)Nov 30, 2022	(FY)Aug 31, 2022	(Q4)Aug 31, 2022
Total revenue	8.10%84K	624.09%145K	54.78%151.28K	-11.43%226.21K	-72.34%30.74K	-22.07%77.71K	-34.67%20.03K	604.14%97.74K	-64.66%255.4K	258.31%111.15K
Operating revenue	8.10%84K	624.09%145K	62.51%150.38K	13.67%190.97K	4.04%41.87K	-22.07%77.71K	-34.67%20.03K	1,221.93%92.54K	-76.61%168K	29.30%40.24K
Cost of revenue	0	0	-69.47%4.82K	-56.15%31.5K	0	-31.60%12.75K	-53.69%2.96K	183.57%15.8K	-59.03%71.84K	103.11%41.25K
Gross profit	29.31%84K	749.59%145K	78.74%146.46K	6.08%194.71K	-56.02%30.74K	-19.88%64.96K	-29.66%17.07K	886.04%81.94K	-66.47%183.56K	552.55%69.9K
Operating expense	-25.91%1.83M	-39.36%813.01K	-27.67%1.29M	-1.09%6.73M	39.88%1.14M	-1.34%2.47M	-8.98%1.34M	-11.65%1.78M	9.12%6.8M	-37.68%818.45K
Selling and administrative expenses	51.95%1.25M	-11.99%567.23K	-24.98%711.11K	-38.26%3.06M	39.41%644.45K	-52.77%825.18K	-46.17%644.51K	-38.97%947.87K	-0.23%4.96M	-47.08%462.26K
-General and administrative expense	51.95%1.25M	-11.99%567.23K	-24.98%711.11K	-38.26%3.06M	39.41%644.45K	-52.77%825.18K	-46.17%644.51K	-38.97%947.87K	-0.23%4.96M	-47.08%462.26K
Research and development costs	-65.07%573.09K	-64.70%245.78K	-30.74%574.49K	98.99%3.67M	40.49%500.41K	118.14%1.64M	152.53%696.18K	80.83%829.49K	45.91%1.84M	-19.01%356.19K
Operating profit	27.40%-1.74M	49.53%-668.01K	32.81%-1.14M	1.28%-6.53M	-48.84%-1.11M	0.72%-2.4M	8.63%-1.32M	15.38%-1.7M	-16.39%-6.62M	42.54%-748.55K
Net non-operating interest income expense	0	-100.01%-1	95.64%7.32K	43.19K	9.02K	15.44K	14.99K	3.74K	0
Non-operating interest income	--0	----	95.64%7.32K	--43.19K	--9.02K	--15.44K	--14.99K	--3.74K	--0	----
Non-operating interest expense	----	--1	----	----	----	----	----	----	----	----
Other net income (expense)	-2,330.23%-41.39K	862.51%15.27K	31.45%-53.22K	71.01%-221.69K	-143.92K	1.86K	-2K	-77.63K	-150.21%-764.61K
Gain on sale of security	-2,330.23%-41.39K	862.51%15.27K	31.45%-53.22K	71.01%-221.69K	---143.92K	--1.86K	---2K	---77.63K	---764.61K	----
Income before tax	25.14%-1.78M	50.20%-652.73K	33.02%-1.19M	9.09%-6.71M	17.46%-1.25M	1.44%-2.38M	9.53%-1.31M	11.69%-1.77M	-77.31%-7.38M	-16.16%-1.51M
Income tax
Net income	25.14%-1.78M	50.20%-652.73K	33.02%-1.19M	9.09%-6.71M	17.46%-1.25M	1.44%-2.38M	9.53%-1.31M	11.69%-1.77M	-76.38%-7.38M	-16.16%-1.51M
Net income continuous Operations	25.14%-1.78M	50.20%-652.73K	33.02%-1.19M	9.09%-6.71M	17.46%-1.25M	1.44%-2.38M	9.53%-1.31M	11.69%-1.77M	-77.31%-7.38M	-16.16%-1.51M
Minority interest income	78.29%-2.62K	74.46%-3.19K	57.23%-5.72K	58.34%-47.63K	78.78%-9.7K	65.94%-12.06K	45.38%-12.51K	-29.41%-13.36K	28.16%-114.33K	63.32%-45.7K
Net income attributable to the parent company	24.87%-1.78M	49.96%-649.54K	32.84%-1.18M	8.31%-6.66M	15.55%-1.24M	0.48%-2.37M	8.95%-1.3M	11.90%-1.76M	-80.51%-7.27M	-24.56%-1.47M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	24.87%-1.78M	49.96%-649.54K	32.84%-1.18M	8.31%-6.66M	15.55%-1.24M	0.48%-2.37M	8.95%-1.3M	11.90%-1.76M	-80.51%-7.27M	-24.56%-1.47M
Basic earnings per share	64.86%-0.13	72.73%-0.06	56.67%-0.13	18.55%-1.01	50.00%-0.12	9.76%-0.37	12.00%-0.22	14.29%-0.3	-30.53%-1.24	0.00%-0.24
Diluted earnings per share	64.86%-0.13	72.73%-0.06	56.67%-0.13	18.55%-1.01	50.00%-0.12	9.76%-0.37	12.00%-0.22	14.29%-0.3	-30.53%-1.24	0.00%-0.24
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall